Clinical Trials in Tennessee

Showing 10961-10980 of 20,239 trials

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

NCT04073017

This is an open-label phase II basket study evaluating the ability of enterade® to reduce bowel frequency in neuroendocrine tumor (NET) patients with carcinoid syndrome and non-carcinoid syndrome.

Neuroendocrine TumorCarcinoid Syndrome

Vanderbilt-Ingram Cancer Center11 participantsStarted Nov 2019

Nashville, Tennessee, United States

COMPLETEDPhase 329 miles

Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU

NCT01889862

The BMN 165 clinical development program has been designed to demonstrate the safety and efficacy of BMN 165 in reducing blood Phe concentrations in adults with PKU.

Phenylketonuria (PKU)

BioMarin Pharmaceutical215 participantsStarted Jul 2013

La Jolla, California, United States • Oakland, California, United States • Aurora, Colorado, United States +26 more locations

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU

Find Trials by Condition in Tennessee

GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

Uphold LITE Post-Market Surveillance Study

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

Gammagard Liquid and rHuPH20 in PID

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T

Impact of Pre-transplant Anti-fibrotic Therapy for IPF Upon Lung Transplant Outcomes

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer

A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test

Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS